Cases & Deals

Abbott acquires Tendyne Holdings

Clients Abbott Laboratories

Jones Day acted as tax counsel to Abbott Laboratories in connection with its $250 million acquisition of Tendyne Holdings, Inc., a private medical device company focused on developing minimally invasive mitral valve replacement therapies.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.